Laws, Mary J.
Ziegler, Yvonne
Shahoei, Sayyed Hamed
Dey, Parama
Kim, Sung Hoon
Yasuda, Mayuri
Park, Ben Ho
Nettles, Kendall W.
Katzenellenbogen, John A.
Nelson, Erik R.
Katzenellenbogen, Benita S. http://orcid.org/0000-0002-8847-2752
Funding for this research was provided by:
Breast Cancer Research Foundation (BCRF-083, BCRF-084, IIDRP-16-006)
National Cancer Institute (1R01CA220284)
Susan G. Komen (170079)
National Institutes of Health (R01CA234025)
DOD Peer Reviewed Cancer Research Program (BC171214)
Article History
Received: 7 February 2020
Accepted: 3 April 2020
First Online: 10 April 2020
Compliance with ethical standards
:
: JAK is a consultant and stockholder of Radius Health, Inc. BSK and JAK have ownership interest in Celcuity, Inc. Patent applications covering K-07 that include JAK, SHK, and BSK as inventors have been filed by the University of Illinois. BHP receives royalties from Horizon Discovery, LTD, was a scientific advisory board member for Loxo Oncology and had ownership interest in Loxo Oncology, was a paid consultant for Foundation Medicine, Inc., H3 Biomedicine, Casdin Capital, Roche, Eli Lilly, Astra Zeneca, is an unpaid consultant for Tempus, and is a paid consultant for Jackson Laboratories, Celcuity, Pathovax, with ownership interest in Celcuity, and has research contracts with Abbvie, Foundation Medicine Inc. and Pfizer. The other authors declare that they have no conflict of interest.
: All applicable international, national, and/or institutional guidelines for the care and use of animals were followed. All animal experiments were performed in accordance with institutional protocols and approved by the University of Illinois Institutional Animal Care and Use Committee (PHS Assurance: D16-00,075 (A3118-01)). This article does not contain any studies with human participants performed by any of the authors.
: Not applicable.